Jiangsu Keben Pharmaceutical

Jiangsu Keben Pharmaceutical is a specialized pharmaceutical enterprise focused on the research, development, and industrialization of high-end Active Pharmaceutical Ingredients (APIs) and chemical intermediates. Headquartered in Taizhou, Jiangsu, the company maintains a strong presence in the cardiovascular and metabolic therapeutic areas, producing key generic components such as Rivaroxaban and Sitagliptin. Keben operates state-of-the-art manufacturing facilities that adhere to international GMP standards, enabling it to serve both domestic and global markets. The company also provides comprehensive CDMO services, leveraging its expertise in complex organic synthesis and process optimization.